Empirical Antimicrobial Therapy for Febrile Granulocytopenic Cancer Patients: Lessons from Four EORTC Trials
- 1 January 1988
- book chapter
- Published by Springer Nature
- Vol. 108, 53-60
- https://doi.org/10.1007/978-3-642-82932-1_8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1986
- Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopeniaAmerican Journal Of Medicine, 1984
- Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapyEuropean Journal of Cancer and Clinical Oncology, 1984
- Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer.Journal of Clinical Oncology, 1983
- Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infectionsAntimicrobial Agents and Chemotherapy, 1983
- Synergistic Combinations of Antibiotics in Gram-Negative Bacillary InfectionsClinical Infectious Diseases, 1982
- In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1981
- Three Antibiotic Regimens in the Treatment of Infection in Febrile Granulocytopenic Patients with CancerThe Journal of Infectious Diseases, 1978